CompoAtlas

StingEze

Natural health product licensed in Canada

Licence holder
Wisconsin Pharmacal Co., LLC
NPN or DIN-HM
80073836
Status
Active licence
Licence date
17 November 2016
Revision date
Not provided
Form
Solution
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
DL-camphre

Source : dl-Camphre

3 Pour cent
Acide 4-aminobenzoïque, Ester d'éthyle

Source : Benzocaine

5 Pour cent
Phenol

Source : Phénol

1.35 Pour cent

Non-medicinal ingredients

Eau purifiée, propylèneglycol

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 2 yearsNot specifiedminimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

For temporary relief of pain and/or itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites or minor skin irritations.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80073836

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line